S&P 500 · Health Care · USD · FY end 2025-12-27
Charles River Laboratories (CRL) financials — revenue, earnings, margins, balance sheet, cash flow and dividends. 10-year history sourced from SEC filings.
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| FY2025 | 4.02B | -144.34M | -2.91 | 518.49M |
| FY2024 | 4.05B | 22.20M | 0.20 | 501.61M |
| FY2023 | 4.13B | 474.62M | 9.22 | 365.37M |
| FY2022 | 3.98B | 486.23M | 9.48 | 294.91M |
| FY2021 | 3.54B | 390.98M | 7.60 | 532.03M |